Citurgia Biochemicals Ltd (CITURGIBIO) is currently trading at 102.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Citurgia Biochemicals Limited is an Indian specialty chemicals manufacturer focused on producing citric acid, calcium carbonate and plasticisers, operating manufacturing facilities historically including a Rishikesh plant and exporting citric acid to markets such as the US, Japan, Germany, Australia, Iran, Malaysia and Sri Lanka while also having undertaken past modernization projects and effluent-treatment investments. The company’s latest published quarterly results for the quarter ended 30 June 2026 show zero reported revenue from operations, total expenses of Rs. 8.20 lakhs and a net loss of Rs. 8.20 lakhs, with year ended loss aggregating Rs. 74.25 lakhs; earnings per share reported as effectively nil and the Board approved the unaudited results on 12 August 2026. Citurgia has a lengthy history of operational disruption and corporate distress: past lockout at Rishikesh, BIFR registration and rehabilitation proceedings, a pending Supreme Court appeal related to rehabilitation, and intermittent suspension of calcium carbonate operations driven by working capital shortages and environmental clearances, which continue to constrain current throughput and revenue generation. Historically the company invested in pollution control and fuel efficiency — commissioning an anaerobic effluent-treatment plant and modernizing to a Fluidized Bed Combustion coal-fired boiler — demonstrating some capital investment focus on operating efficiency and environmental compliance, while also pursuing non-core real estate construction at Rishikesh in prior years as an alternate revenue or asset strategy.

Over the past 52 weeks, Citurgia Biochemicals Ltd has traded between a low of ₹47.40 and a high of ₹212.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Citurgia Biochemicals Ltd has a market capitalization of approximately 1,353.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Citurgia Biochemicals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -1828.81 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,353.32 Cr, Citurgia Biochemicals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Citurgia Biochemicals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Citurgia Biochemicals Ltd is -1828.81. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.